Fakher HE, Mehanna ET, Zidan AA, Mesbah NM, et al. Integrating biochemical and computational approaches to identify targeted therapeutic strategies for liver fibrosis: Effects of Telaglenastat (CB-839) on the glutaminase pathway. Biochem Biophys Res Commun 2026;795:153101.
PMID: 41365161